Stemline Therapeutics (STML) PT Lowered to $14 at Wedbush

January 16, 2020 7:26 AM EST
Get Alerts STML Hot Sheet
Price: $11.83 --0%

Rating Summary:
    6 Buy, 4 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 26 | New: 41
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Wedbush analyst David Nierengarten lowered the price target on Stemline Therapeutics (NASDAQ: STML) to $14.00 (from $17.00) while maintaining a Outperform rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change